Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Catalyst Pharmaceuticals Inc CPRX

Healthcare Biotechnology
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5... see more

Current News (NDAQ:CPRX)

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 14 hours ago

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

GlobeNewswire November 24, 2025

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500(TM)

GlobeNewswire November 19, 2025

Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

GlobeNewswire November 18, 2025

Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 5, 2025

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

GlobeNewswire November 4, 2025

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

GlobeNewswire November 3, 2025

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

GlobeNewswire October 22, 2025

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

GlobeNewswire October 9, 2025
View More News ››

Opinion & Analysis (NDAQ:CPRX)

Final Approval of Biopharma's Lead Candidate Both Likely and Imminent

Streetwise Reports September 7, 2018
View More Opinion ››

Bullboard Posts (NDAQ:CPRX)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Eevhie - April 13, 2023

CATALYST PHARMACEUTICALS: NEXT BIG THING ON S&P SMALLCAP 600

$CPRX Excited to share an article about Catalyst Pharmaceuticals, Inc (NASDAQ: CPRX), a commercial-stage biopharmaceutical company...
AviseAnalytics - September 14, 2022

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
Eevhie - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Eevhie - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

Eevhie - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Eevhie - May 10, 2022
View more Bullboard ››

Sparta Capital Ltd.

Sparta Capital Ltd.

Sparta Capital Ltd. engages in environment, health, and transportation businesses in Canada. It operates through Electronics ...
View More »